Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.

Nakhjavani, Maryam; Hardingham, Jennifer E; Palethorpe, Helen M; Price, Tim J; Townsend, Amanda R

Nakhjavani, Maryam; Hardingham, Jennifer E; Palethorpe, Helen M; Price, Tim J; Townsend, Amanda R.

Afiliação

Nakhjavani M; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, Australia.
Hardingham JE; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
Palethorpe HM; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, Australia.
Price TJ; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
Townsend AR; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, Australia.

J Breast Cancer ; 22(3): 341-361, 2019 09.

Article em En | MEDLINE | ID: mdl-31598336

Palavras-chave

Clinical trial; Drug therapy; Triple negative breast neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Breast Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google